news in brief

Xellia starts work on Copenhagen sterile drug plant

By Gareth Macdonald contact

- Last updated on GMT

Gettyimages/grThirteen
Gettyimages/grThirteen
Xellia Pharmaceutical ApS has started constructing a sterile manufacturing building at its plant in Copenhagen, Denmark.

The building – which cost $25m (€21m) – will increase production capacity for both active pharmaceutical ingredients (APIs) and finished dose anti-infective pharmaceuticals like vancomycin and colistimethate sodium. 

In August​, Xellia completed the expansion of its API and drug product testing facility in Budapest, Hungary.

The firm is also expanding its US sterile injectables with a production facility in Cleveland, Ohio, which is scheduled to open next year. The facility will complement an existing plant in Raleigh, North Carolina.

Related topics: Ingredients

Related news

Show more